Altium Capital Management LP Biovie Inc. Transaction History
Altium Capital Management LP
- $188 Million
- Q2 2024
A detailed history of Altium Capital Management LP transactions in Biovie Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 1,982,341 shares of BIVI stock, worth $5.49 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
1,982,341
Previous 3,012,608
34.2%
Holding current value
$5.49 Million
Previous $1.6 Million
50.38%
% of portfolio
0.42%
Previous 0.9%
Shares
2 transactions
Others Institutions Holding BIVI
# of Institutions
45Shares Held
4.73MCall Options Held
17.2KPut Options Held
27K-
Sabby Management, LLC Upper Saddle River, NJ733KShares$2.03 Million19.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA568KShares$1.57 Million0.0% of portfolio
-
Swisspartners Ltd. Vaduz, N2294KShares$815,3382.92% of portfolio
-
Geode Capital Management, LLC Boston, MA232KShares$641,6870.0% of portfolio
-
Jane Street Group, LLC New York, NY176KShares$488,1730.0% of portfolio
About BIOVIE INC.
- Ticker BIVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,165,300
- Market Cap $83.6M
- Description
- BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...